EUVIMEDEUVIMED entdecken
Open Access

Relationship Between Obstructive Sleep Apnea Severity and Serum Endocan Levels in Patients With Hypertension

Serkan Yazan, Hüseyin Karakurt, Hamdi Püşüroğlu

Texas Heart Institute Journal · 2023

DOI: 10.14503/thij-21-7664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Texas Heart Institute Journal, 2023. Verfasst von Serkan Yazan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanb…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Hypertension, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obstructive sleep apnea (OSA) is common in middle-aged adults and has been associated with various cardiovascular disorders; endothelial dysfunction may play a role in the pathogenesis of these disorders in patients with OSA. Endothelial cell specific molecule-1 (endocan) is a marker of vascular pathology, which is correlated with endothelial dysfunction. This study investigates the relationship between serum endocan levels and OSA severity in patients with hypertension.

Methods

A retrospective review included 48 patients with OSA and hypertension but without conventional cardiovascular risk factors, and 67 patients with OSA who did not have hypertension. The correlation between serum endocan levels and the apnea-hypopnea index (AHI) was investigated in both groups.

Results

There was a significant correlation between the serum endocan level and the AHI in patients with OSA and hypertension ( r = 0.308; P = .033), but there was no such correlation in patients without hypertension ( r = 0.193; P = .118). However, when both groups were combined (ie, all patients with OSA), there was a significant correlation between serum endocan levels and the AHI ( r = 0.228; P = .014). On multiple logistic regression analysis, endocan levels were independent predictors of OSA severity in patients with OSA and hypertension ( P = .029).

Conclusion

In patients with OSA and hypertension, serum endocan levels are significantly correlated with the AHI. Measurement of endocan may have a place in evaluating patients with OSA and hypertension for adverse cardiovascular events, and they may even help to guide OSA therapy for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesHypertensionSleep Apnea, ObstructiveAdultHumansMiddle AgedBiomarkersPolysomnography

Stichwörter der Autor:innen

ESM1 protein, humanHypertensionsleep apnea, obstructive

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Cardiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.

Zitieren

APA

Yazan, S., Karakurt, H., & Püşüroğlu, H. (2023). Relationship Between Obstructive Sleep Apnea Severity and Serum Endocan Levels in Patients With Hypertension. Texas Heart Institute Journal. https://doi.org/10.14503/thij-21-7664

Vancouver

Yazan S, Karakurt H, Püşüroğlu H. Relationship Between Obstructive Sleep Apnea Severity and Serum Endocan Levels in Patients With Hypertension. Texas Heart Institute Journal. 2023. doi:10.14503/thij-21-7664

BibTeX
@article{Yazan2023,
  author = {Yazan, Serkan and Karakurt, Hüseyin and Püşüroğlu, Hamdi},
  title = {Relationship Between Obstructive Sleep Apnea Severity and Serum Endocan Levels in Patients With Hypertension},
  journal = {Texas Heart Institute Journal},
  year = {2023},
  doi = {10.14503/thij-21-7664}
}
Kostenlos starten →